IP Library Granted Patent US 7,576,130
Granted Patent B2
US 7,576,130 · App. 11/928,045 · Granted Aug 18, 2009

Dihydroxyl compounds and compositions for cholesterol management and related uses

Assignee: Esperion Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,576,130
App. No.
11/928,045
Granted
Aug 18, 2009
Kind
B2
Abstract

The present invention relates to novel dihydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

Claims (10)

1. A method for the treatment of cardiovascular disease comprising the administration to a human of an effective amount of a compound selected from a compound of structure

or a pharmaceutically acceptable salt thereof.

2. A method according to claim 1 wherein the compound has the structure:

or a pharmaceutically acceptable salt thereof.

3. A method according to claim 1 wherein the compound has the structure:

or a pharmaceutically acceptable salt thereof.

4. A method according to claim 1 wherein the compound has the structure:

or a pharmaceutically acceptable salt thereof.

5. A method according to claim 1 wherein the compound has the structure:

or a pharmaceutically acceptable salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2014
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033943/0672 →
MERGER Recorded Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
Continuity (3)
Division 1074310900 · Dec 23, 2003
Provisional Application 6044179500 · Jan 23, 2003
Related Publication 20080064661A1 · Mar 13, 2008